SPIKE Act
Bill journey · stage 1 of 5
Just introduced
What it doesSummary introduced in house (Apr 3, 2019)
Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.
What just happenedMay 21, 2019
Subcommittee Hearings Held.
Who’s behind it
- Introduced in HouseApr 3, 2019
- May 21, 2019Committee
Subcommittee Hearings Held.
Health Subcommittee - Apr 4, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 3, 2019Committee
Referred to the Subcommittee on Health.
Ways and Means CommitteeHealth Subcommittee - Apr 3, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 3, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 3, 2019IntroReferralIntro-H
Introduced in House
- Apr 3, 2019IntroReferral1000
Introduced in House